Molecular markers for the classification of cytologically indeterminate thyroid nodules
$ 15.00
-
By A Mystery Man Writer
-
-
4.9(456)
Product Description
PDF) Molecular Tests for Risk-Stratifying Cytologically Indeterminate Thyroid Nodules: An Overview of Commercially Available Testing Platforms in the United States
Follow-up of patients with indeterminate nodule at cytology and thyroid
Predicting malignancy in thyroid nodules with benign cytology results: The role of Conventional Ultrasound, Shear Wave Elastography and BRAF V600E - IOS Press
Initial Evaluation ‣ Differentiated Thyroid Cancer
Approaching Indeterminate Thyroid Nodules in the Absence of Molecular Markers: The BETH-TR Score. - Abstract - Europe PMC
Evaluation and Management of Indeterminate Thyroid Nodules: The Revolution of Risk Stratification Beyond Cytological Diagnosis - Pablo Valderrabano, Bryan McIver, 2017
Risk assessment of cytologically indeterminate thyroid nodules with integrated molecular testing and repeat biopsy: a surgical decision-oriented tool, World Journal of Surgical Oncology
Determination of “Indeterminate” Thyroid Nodules
Current controversies in the management of patients with indeterminate thyroid nodules
Thyroid nodules: diagnostic evaluation based on thyroid cancer risk assessment
Diagnostic Utility of Molecular and Imaging Biomarkers in Cytological Indeterminate Thyroid Nodules. - Document - Gale OneFile: Health and Medicine
Role of Molecular Markers in Thyroid Nodule Management: Then and Now - ScienceDirect
SciELO - Brasil - Can current molecular tests help in the diagnosis of indeterminate thyroid nodule FNAB? Can current molecular tests help in the diagnosis of indeterminate thyroid nodule FNAB?
